Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Mary G. Amato"'
Autor:
Rachel Leah Wasserman, Diane L. Seger, Mary G. Amato, Zoe Co, Aqsa Mugal, Angela Rui, Pamela M. Garabedian, Marlika Marceau, Ania Syrowatka, Lynn A. Volk, David W. Bates
Publikováno v:
Journal of the Medical Library Association, Vol 112, Iss 1 (2024)
Objective: To evaluate the ability of DynaMedex, an evidence-based drug and disease Point of Care Information (POCI) resource, in answering clinical queries using keyword searches. Methods: Real-world disease-related questions compiled from clinicia
Externí odkaz:
https://doaj.org/article/d4b288e86a8541568b0dadbc11ac95c6
Autor:
Ania Syrowatka, PhD, Wenyu Song, PhD, Mary G Amato, PharmD, Dinah Foer, MD, Heba Edrees, PharmD, Zoe Co, BS, Masha Kuznetsova, MPH, Sevan Dulgarian, BS, Diane L Seger, RPh, Aurélien Simona, MD, Paul A Bain, PhD, Gretchen Purcell Jackson, MD, Kyu Rhee, MD, David W Bates, ProfMD
Publikováno v:
The Lancet: Digital Health, Vol 4, Iss 2, Pp e137-e148 (2022)
Summary: Adverse drug events (ADEs) represent one of the most prevalent types of health-care-related harm, and there is substantial room for improvement in the way that they are currently predicted and detected. We conducted a scoping review to ident
Externí odkaz:
https://doaj.org/article/b4a56145798f4970a110fd2638bae3d2
Autor:
David W. Bates, David M. Levine, Hojjat Salmasian, Ania Syrowatka, David M. Shahian, Stuart Lipsitz, Jonathan P. Zebrowski, Laura C. Myers, Merranda S. Logan, Christopher G. Roy, Christine Iannaccone, Michelle L. Frits, Lynn A. Volk, Sevan Dulgarian, Mary G. Amato, Heba H. Edrees, Luke Sato, Patricia Folcarelli, Jonathan S. Einbinder, Mark E. Reynolds, Elizabeth Mort
Publikováno v:
New England Journal of Medicine. 388:142-153
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31cc823d8c6f58a5ad24c0899161fd70
https://doi.org/10.1056/nejmsa2206117
https://doi.org/10.1056/nejmsa2206117
Autor:
Alejandra, Salazar, Mary G, Amato, Sonam N, Shah, Maram, Khazen, Saina, Aminmozaffari, Elissa V, Klinger, Lynn A, Volk, Maria, Mirica, Gordon D, Schiff
Publikováno v:
American Journal of Health-System Pharmacy. 80:207-214
In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce693c0e8dee27ee104610d61de27367
https://doi.org/10.1093/ajhp/zxac325
https://doi.org/10.1093/ajhp/zxac325
Autor:
Angela Rui, Pamela M Garabedian, Marlika Marceau, Ania Syrowatka, Lynn A Volk, Heba H Edrees, Diane L Seger, Mary G Amato, Jacob Cambre, Sevan Dulgarian, Lisa P Newmark, Karen C Nanji, Petra Schultz, Gretchen Purcell Jackson, Ronen Rozenblum, David W Bates
BACKGROUND Evidence-based point-of-care information (POCI) tools can facilitate patient safety and care by helping clinicians to answer disease state and drug information questions in less time and with less effort. However, these tools may also be v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb6e4aed1330dbe64a933cc5eab2f59f
https://doi.org/10.2196/preprints.48468
https://doi.org/10.2196/preprints.48468
Publikováno v:
Drug Safety. 45:449-458
Pharmacovigilance improves patient safety by detecting and preventing adverse drug events. However, challenges exist that limit adverse drug event detection, resulting in many adverse drug events being underreported or inaccurately reported. One chal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44b664b858e8df496e76a770bb86c42d
https://doi.org/10.1007/s40264-022-01172-5
https://doi.org/10.1007/s40264-022-01172-5
Autor:
Angela Rui, Pamela M Garabedian, Marlika Marceau, Ania Syrowatka, Lynn A Volk, Heba H Edrees, Diane L Seger, Mary G Amato, Jacob Cambre, Sevan Dulgarian, Lisa P Newmark, Karen C Nanji, Petra Schultz, Gretchen Purcell Jackson, Ronen Rozenblum, David W Bates
BACKGROUND Evidence-based point-of-care information (POCI) tools can facilitate patient safety and care by helping clinicians to answer disease state and drug information questions in less time and with less effort. However, these tools may also be v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb9a0a6e2fd5ac39ff1db97026667d05
https://doi.org/10.2196/preprints.43960
https://doi.org/10.2196/preprints.43960
Autor:
Angela Rui, Pamela M Garabedian, Marlika Marceau, Ania Syrowatka, Lynn A Volk, Heba H Edrees, Diane L Seger, Mary G Amato, Jacob Cambre, Sevan Dulgarian, Lisa P Newmark, Karen C Nanji, Petra Schultz, Gretchen Purcell Jackson, Ronen Rozenblum, David W Bates
Publikováno v:
JMIR Human Factors. 10:e48468
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::18ead7af855fb449d7657eb810e3806e
https://doi.org/10.2196/48468
https://doi.org/10.2196/48468
Autor:
Angela Rui, Pamela M Garabedian, Marlika Marceau, Ania Syrowatka, Lynn A Volk, Heba H Edrees, Diane L Seger, Mary G Amato, Jacob Cambre, Sevan Dulgarian, Lisa P Newmark, Karen C Nanji, Petra Schultz, Gretchen Purcell Jackson, Ronen Rozenblum, David W Bates
Publikováno v:
JMIR Human Factors. 10:e43960
Background Evidence-based point-of-care information (POCI) tools can facilitate patient safety and care by helping clinicians to answer disease state and drug information questions in less time and with less effort. However, these tools may also be v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1cf251f8ba110c5aad8c2bb8d2812109
https://doi.org/10.2196/43960
https://doi.org/10.2196/43960
Autor:
Dariel Delos Reyes, Mary G. Amato, Diane L. Seger, Joel B. Krier, Maryam Alobaidly, Sarah Hasan, Sonam N. Shah, Roseann S. Gammal, David W. Bates
Publikováno v:
Drug Safety. 44:601-607
Medication-related harm represents a significant issue for patient safety and quality of care. One strategy to avoid preventable adverse drug events is to utilize patient-specific factors such as pharmacogenomics (PGx) to individualize therapy. We me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::15d4037e197d729058723768ebd5cc7e
https://doi.org/10.1007/s40264-021-01050-6
https://doi.org/10.1007/s40264-021-01050-6